B1 Non-refereed article in a scientific journal

Reply to Tuomas Mirtti and Tero Aittokallio's Letter to the Editor re: Fatemeh Seyednasrollah, Mehrad Mahmoudian, Liisa Rautakorpi, et al. How Reliable are Trial-based Prognostic Models in Real-world Patients with Metastatic Castration-resistant Prostate Cancer? Eur Urol. 2017;71:838-40. Clinical Utility of Trial-estimated Prognostic Models.

Authors: Seyednasrollah F, Mahmoudian M, Rautakorpi L, Hirvonen O, Laitinen T, Jyrkkiö S, Elo LL

Publication year: 2017

Journal:European Urology

Volume: 72

Issue: 3

First page : E70

Last page: E71

Number of pages: 2

ISSN: 0302-2838

DOI: https://doi.org/10.1016/j.eururo.2017.04.031